Trial Outcomes & Findings for Social Phobia Intervention Study of Mannheim (NCT NCT00434759)

NCT ID: NCT00434759

Last Updated: 2012-11-28

Results Overview

This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

89 participants

Primary outcome timeframe

baseline to post-treatment (on average 24 weeks)

Results posted on

2012-11-28

Participant Flow

Participant milestones

Participant milestones
Measure
Stepped Care Program
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission
Standardtherapy
standard therapy (therapist-guided intervention only)
Overall Study
STARTED
46
43
Overall Study
COMPLETED
22
38
Overall Study
NOT COMPLETED
24
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Stepped Care Program
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission
Standardtherapy
standard therapy (therapist-guided intervention only)
Overall Study
Lack of Efficacy
5
4
Overall Study
Withdrawal by Subject
17
1
Overall Study
family affairs
2
0

Baseline Characteristics

Social Phobia Intervention Study of Mannheim

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only)
Total
n=89 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
46 Participants
n=5 Participants
43 Participants
n=7 Participants
89 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age Continuous
37.26 years
STANDARD_DEVIATION 10.47 • n=5 Participants
38.47 years
STANDARD_DEVIATION 10.26 • n=7 Participants
37.84 years
STANDARD_DEVIATION 10.33 • n=5 Participants
Sex: Female, Male
Female
24 Participants
n=5 Participants
24 Participants
n=7 Participants
48 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
19 Participants
n=7 Participants
41 Participants
n=5 Participants
Region of Enrollment
Germany
46 participants
n=5 Participants
43 participants
n=7 Participants
89 participants
n=5 Participants

PRIMARY outcome

Timeframe: baseline to post-treatment (on average 24 weeks)

Population: Intention-to-Treat

This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.

Outcome measures

Outcome measures
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only; 16 sessions)
Change From Baseline in Social Interaction Anxiety Scale (SIAS)
baseline
43.13 units on a scale
Standard Deviation 14.26
48.94 units on a scale
Standard Deviation 11.00
Change From Baseline in Social Interaction Anxiety Scale (SIAS)
post-treatment
34.85 units on a scale
Standard Deviation 14.86
33.35 units on a scale
Standard Deviation 16.90

PRIMARY outcome

Timeframe: baseline to post-treatment (on average 24 weeks)

Population: Intention-to-Treat

The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.

Outcome measures

Outcome measures
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only; 16 sessions)
Change From Baseline in Social Phobia Scale (SPS)
baseline
35.85 units on a scale
Standard Deviation 14.97
33.95 units on a scale
Standard Deviation 13.12
Change From Baseline in Social Phobia Scale (SPS)
post-treatment
24.89 units on a scale
Standard Deviation 17.41
17.58 units on a scale
Standard Deviation 13.36

PRIMARY outcome

Timeframe: baseline to post-treatment (on average 24 weeks)

Population: Intention-to-Treat

The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.

Outcome measures

Outcome measures
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only; 16 sessions)
Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)
baseline
57.46 units on a scale
Standard Deviation 23.61
60.58 units on a scale
Standard Deviation 19.37
Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)
post-treatment
41.22 units on a scale
Standard Deviation 23.49
31.84 units on a scale
Standard Deviation 21.57

SECONDARY outcome

Timeframe: baseline to post-treatment (on average 24 weeks)

Population: Intention-to-Treat

The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.

Outcome measures

Outcome measures
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only; 16 sessions)
Change From Baseline in Brief Symptom Inventory (BSI)
baseline
1.00 units on a scale
Standard Deviation 0.59
0.90 units on a scale
Standard Deviation 0.56
Change From Baseline in Brief Symptom Inventory (BSI)
post-treatment
0.71 units on a scale
Standard Deviation 0.51
0.51 units on a scale
Standard Deviation 0.51

SECONDARY outcome

Timeframe: baseline to post-treatment (on average 24 weeks)

Population: Intention-to-Treat

The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.

Outcome measures

Outcome measures
Measure
Stepped Care Program
n=46 Participants
stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)
Standardtherapy
n=43 Participants
standard therapy (therapist-guided intervention only; 16 sessions)
Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)
baseline
21.48 units on a scale
Standard Deviation 9.97
21.47 units on a scale
Standard Deviation 11.04
Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)
post-treatment
16.20 units on a scale
Standard Deviation 10.26
14.28 units on a scale
Standard Deviation 9.93

Adverse Events

Stepped Care Program

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standardtherapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof. Martin Bohus

Central Institute of Mental Health, Mannheim, Germany

Phone: +49 621 1703 4002

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place